Rekombinanter IL23A (Guselkumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IL23A (Guselkumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Mammalian Cells
- Expressionssystem
- Mammalian cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL23A (Guselkumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- ELISA
- Verwendungszweck
- Guselkumab Biosimilar - Anti-IL23A mAb
- Produktmerkmale
- Antibody Type: IgG1-lambda
- Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 lambda
-
anti-IL23A (Guselkumab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade Reaktivität: Human ELISA Wirt: Humanized Monoclonal unconjugated
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- -80 °C
- Informationen zur Lagerung
- store at -80°C
-
- Target
- IL23A (Guselkumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
-
CNTO-1959
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. - CAS-Nummer
- 1350289-85-8
-
Sie sind hier:
